CN103146739A - Establishing method of bifidobacterium functional gene no-trace knockout method - Google Patents

Establishing method of bifidobacterium functional gene no-trace knockout method Download PDF

Info

Publication number
CN103146739A
CN103146739A CN2013100708858A CN201310070885A CN103146739A CN 103146739 A CN103146739 A CN 103146739A CN 2013100708858 A CN2013100708858 A CN 2013100708858A CN 201310070885 A CN201310070885 A CN 201310070885A CN 103146739 A CN103146739 A CN 103146739A
Authority
CN
China
Prior art keywords
gene
serpin
spc
bifidobacterium
bifidus bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100708858A
Other languages
Chinese (zh)
Other versions
CN103146739B (en
Inventor
万翠香
魏华
夏慧玲
许恒毅
章昭琳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanchang University
Original Assignee
Nanchang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanchang University filed Critical Nanchang University
Priority to CN201310070885.8A priority Critical patent/CN103146739B/en
Publication of CN103146739A publication Critical patent/CN103146739A/en
Application granted granted Critical
Publication of CN103146739B publication Critical patent/CN103146739B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses an establishing method of a bifidobacterium functional gene no-trace knockout method. The establishing method comprises the following steps of: constructing a serpin gene suicide type targeting vector UPD; loading a promoter of the bifidobacterium by using pDG7 as a framework to construct a bifidobacterium-escherichia coli shuttle expression vector pDG-Hup; constructing a bifidobacterium-escherichia coli shuttle expression vector Pdg-hup-cre of a Cre enzyme gene based on pDG-Hup; transferring the targeting vector into the bifidobacterium and obtaining a bifidobacterium serpin gene defective strain through homologous recombination; and removing the spectinomycin spc gene introduced in the bifidobacterium genome by utilizing a site-specific recombination Cre-loxp system to realize no-trace knockout of the bifidobacterium resistance gene. The establishing method of the bifidobacterium functional gene no-trace knockout method disclosed by the invention is used for obtaining the defective strain of the bifidobacterium functional gene by utilizing a homologous recombination principle, can be applied to the knockout of the bifidobacterium functional gene and can be used for improving the strains.

Description

The foundation of the seamless knockout technique of bifidus bacillus functional gene
Technical field
The invention belongs to the application in the bifidus bacillus genetically engineered, specifically relate to the seamless knockout technique of a kind of bifidus bacillus functional gene.
Background technology
Gene knockout is a kind of mode of modifying native gene of utilizing DNA homology restructuring principle to carry out, make between the target gene homologous sequence on foreign DNA and recipient cell genomic dna and recombinate, foreign vector DNA site-directed integration is entered on the predetermined site of target gene, or replace with a certain DNA fragmentation of target gene, complete accurate modification and transformation to the genomic dna target gene, cause the structure of target gene or the sudden change of composition, cause gene function to be lost, and the gene of modified and transformation can be with copying of genomic dna and stable copying.It has, and polarization is strong, target gene can overcome blindness and the randomness of the random integration of mutagenesis with the characteristics of genomic dna genetic stability after knocking out, and is a kind of desirable modification, the method for transformation microorganism hereditary material.In the Research for Industrial Microbial Germ improvement, flow by pathways metabolism and metabolism that knocking out of target gene changes microorganism, can not only improve the output of leavened prod and produce new meta-bolites, can also improve the artificial regulatory of fermentation industry fermentation approach and process, be the most promising microbial strains improved means of 21 century.
The application of Cre-loxp system in gene targeting can be said to gene target position technology and bring a revolution.The Cre recombinase is a kind of activated protein of molecular weight 38kd that derives from the recombinase family of pl phage.It not only has catalytic activity, and similar with restriction enzyme, identifies special DNA sequence dna, as: the Loxp site causes restructuring.The Loxp site is the specificity recombination site of Cre recombinase effect, formed by 34 bp, that is: and ATAACTTCGTATAGCATACATTATACGAAGTTAT, the interval region of the foldback sequence of two 13 bp and 8 bp consists of.The Cre recombinase has 70% recombination efficiency, not by any cofactor, acts on the DNA substrate of various structures, as linear, ring-type, and superhelix (being become linear structure by the uncoiling of Cre recombinase) even.The Cre recombinase by with the combination in the upper Loxp of DNA site, bring into play its recombination.The Cre/Loxp system is short and pithy, the effect of Cre enzyme is single-minded, and do not affect normal expression and the regulation and control of gene, these characteristics make it in the gene targeting operation, very important effect be arranged, and this system successfully is used for the gene knockout of multiple eukaryotic cell and bacterium at present.
Bifidus bacillus ( Bifidobacterium)Can keep the microecological balance of host's enteron aisle, improve human body to the lactose tolerance, have the blood fat of reduction, antineoplastic action, and can synthesize multivitamin, promote body's immunity.In recent years, preparation and food development that state includes bifidobacteria viable bacteria are rapid, and the bifidus bacillus product puts goods on the market.Abroad, the food that contains bifidus bacillus is also all the fashion, particularly in Japan, Europe and North America.Yet bifidus bacillus is as a kind of gram-positive microorganism, and cell walls is thicker, and it is carried out genetic manipulation is a difficult point always, has limited the progress in bifidus bacillus genetically engineered field.
The present invention is by the conversion of bifidus bacillus, targeting vector and shuttle expression carrier are imported bifidus bacillus step by step, and first with the Cre-loxp system applies in the genetically engineered of gram-positive microorganism bifidus bacillus, realized that successfully the seamless of bifidus bacillus functional gene knocks out, provide means for studying its gene function.
Summary of the invention
The purpose of this invention is to provide the seamless knockout technique of a kind of bifidus bacillus functional gene; The method first with the Cre-loxp system applies in the research of gram-positive microorganism bifidus bacillus, obtained the characteristics such as the seamless gene-deleted strain of bifidus bacillus functional gene.
The concrete technical scheme of the present invention is as follows:
The establishment method of the seamless gene-deleted strain of a kind of bifidus bacillus functional gene comprises the following steps:
(1) SEQ ID.NO.1 is passed through EcoR V site and PstThe I enzyme is cut and is connected on the pUC57 carrier, obtains the pUC57-LoxP carrier;
(2) take the pER8 plasmid as template, by primer SEQ. ID.NO.2 and SEQ. ID.NO.3 amplification, amplified production is passed through XhoI and ApaTwo the cutting afterwards of I is connected with the pUC57-LoxP carrier, builds and obtains carrier pUC-Spc;
(3) with the genome of bifidus bacillus as template, by primer SEQ. ID.NO.4 and SEQ. ID.NO.5 amplification, amplified production is passed through EcoR I and SpeTwo the cutting afterwards of I is connected with the pUC-Spc carrier, builds and obtains carrier pUC-spc-serpin Up800
(4) with the genome of bifidus bacillus as template, by primer SEQ. ID.NO.6 and SEQ. ID.NO.7 amplification, amplified production is passed through BglII and HindIII is two cuts afterwards and pUC-spc-serpin Up800Carrier connects, and builds to obtain targeting vector plasmid pUC-spc-serpin Up+down, i.e. UPD;
(5) SEQ. ID.NO.8 sequence warp EcoRI and SalThe I double digestion is connected to pDG7, builds shuttle expression carrier pDG-Hup;
(6) take the pCrepA plasmid that contains Cre enzyme gene is template, by primer SEQ. ID.NO.9 and SEQ. ID.NO.10 amplification Cre enzyme gene; The amplified production process XhoI and SalI is two cut after, with pDG-Hup, is connected, structure obtains pDG-Hup-Cre;
(7) conversion of targeting vector: add targeting vector plasmid pUC-spc-serpin in the bifidus bacillus protoplastis Up+down, merge conversion; Washing, recovery after recovery are coated on bacterium liquid and cultivate 2-3 d on the regeneration culture medium with spectinomycin, obtain ⊿ serpinStrain;
(8) will ⊿ serpinThe protoplastis competent cell is made in strain, and shuttle expression carrier pDG-Hup-Cre is imported ⊿ serpinConversion is merged in strain, and bacterium colony after transforming is coated on the regeneration culture medium of amicillin resistance, screens the bifidus bacillus of no longer carrying spectinomycin resistance gene SerpinThe seamless gene-deleted strain of gene ⊿ serpin ⊿ spcStrain.
The condition that fusion described in step (7) and step (8) transforms is: join containing in the solution that magnesium ion concentration is 20 ± 1mM/L, 40 ± 1% (v/v) PEG6000 of preheating, merge conversion.
In step (7), described bifidus bacillus protoplast preparation is: the bifidus bacillus of preservation is transferred on the MRS flat board, and 37 ± 1 ℃ of anaerobism are cultivated 20-26 h; Choose a single bacterium colony from flat board, be inoculated in the MRS liquid nutrient medium, 37 ± 1 ℃ of anaerobism are cultivated 20-26h; Transfer in fresh MRS liquid nutrient medium with 3 ± 1%(v/v) inoculum size, 37 ± 1 ℃ of anaerobism are cultivated 20-26 h; Centrifugal collection thalline, resuspended; Adding mutanolysin to final concentration is 4.5-5.5 mg/L, 36-38 ℃ enzymolysis 25-35 minute; Be resuspended in SMM solution, obtain the bifidus bacillus protoplastis.
Preferably, described bifidus bacillus is bifidus longum bb.
Another object of the present invention is to provide a kind of seamless gene-deleted strain of bifidus bacillus functional gene that does not carry spectinomycin resistance gene.
Preferably, the seamless gene-deleted strain of described bifidus bacillus functional gene, it is to be prepared by above-mentioned method.
Advantage of the present invention is: present method substep imports bifidus bacillus with targeting vector and shuttle expression carrier, utilize the principle of homologous recombination, screening has obtained gene-deleted strain, express the Cre recombinase after importing shuttle expression carrier, removed resistant gene, thereby realized that the seamless of bifidus bacillus functional gene knocks out, utilize this method to carry out gene knockout, the recombinant bacterium that obtains does not at last carry any resistance screening mark, can avoid Antibiotic use in its use procedure, for the strain improvement of bifidus bacillus provides means.
Description of drawings
Fig. 1 is the structure schematic diagram of targeting vector UPD.
Fig. 2 is recombinant vectors pUC-Spc double digestion the result, M:1 K marker; The 1:pUC-spc carrier; 2,3:pUC-spc carrier is used respectively XhoI, ApaI double digestion result.
Fig. 3 is recombinant vectors pUC-spc-serpin Up800The double digestion the result, M:1 K marker; 1,2:pUC-spc-serpin Up800Carrier; 3,4: pUC-spc-serpin Up800Carrier is used respectively EcoR I, SpeI double digestion result.
Fig. 4 is targeting vector pUC-spc-serpin Up+downDouble digestion checking electrophoresis result, 1 K marker; 1:pUC-spc-serpin Up+downCarrier is used respectively BglII, HindIII double digestion result; 2:pUC-spc-serpin Up+downCarrier is used respectively XhoI, HindIII double digestion result.
Fig. 5 is the Cre-loxP system schematic.
Fig. 6 is recombinant plasmid pDG-Hup-Cre structural representation.
Fig. 7 is that the pDG-Hup enzyme is cut the result, pDG-HUP transformant double digestion checking 1: γ Hind III 2:pDG7 double digestion ( BamThe H I with SalI) the 3:pDG-HUP double digestion ( BamThe H I with SalI) 4:pDG7 not enzyme cut 5:pDG-HUP not enzyme cut the 6:pDG-HUP double digestion ( BglII with EcoThe R I) the 7:pDG7 double digestion ( BglII with EcoThe R I) 8:DL2000.
Fig. 8 is that the pDG-Hup-Cre enzyme is cut the result, from left to right 1:DL2000; 2:pDG-Hup-Cre; 3:pDG-Hup-Cre; 4: λ Hind III.
Fig. 9 is that pDG-Hup-Cre transforms ⊿ serpinThe dull and stereotyped result of bifidus bacillus.
Figure 10 is the positive transformant collection of illustrative plates of PCR checking, 1:500-15000 bp Wide range maker; 2: spcPositive control; 3/4: spcPrimer PCR detects ⊿ serpinStrain; 5: spcPrimer PCR detects ⊿ serpin ⊿ spcStrain; 6: Serpin Positive control 7/8: SerpinPrimer PCR detects ⊿ serpinStrain; 9: SerpinPrimer PCR detects ⊿ serpin ⊿ spcStrain.
Figure 11 is that PCR checking and enzyme are cut checking pDG-Hup-Cre conversion ⊿ serpinThe bifidus bacillus electrophoretogram.PCR verifies electrophoretogram (left side), the recombinant plasmid electrophoretogram (right side) after enzyme is cut and transformed in the bifidus bacillus body.
Figure 12 bifidus bacillus genome dna electrophoresis figure, 1/2:NCC2705 prime strain genome; 3/4: ⊿ serpinThe pnca gene group; 5/6: ⊿ serpin ⊿ spcThe pnca gene group; M:Wide range marker 500-15000 bp.
The positive transformant dotting of Figure 13 proof diagram A:T-spc is probe, A1: blank, and A2: ⊿ serpin ⊿ spc, A3 ⊿ serpinStrain, A4 ⊿ serpinStrain, A5 Bifidobacterium longum NCC2705 genome (negative control), A6 spc+ (positive control), B:T- SerpinBe probe; B1: blank B2: ⊿ serpin ⊿ spcStrain, B3: ⊿ serpinStrain, B 4: ⊿ serpinStrain, B5: Bifidobacterium longum NCC2705 genome (positive control), B6: Serpin+ (positive control).
Figure 14 is Southern hybridization analysis figure, A: the Southern hybridization figure take T-serpin as probe, B: the Southern hybridization figure take T-spc as probe; A1: ⊿ serpinStrain; A2: ⊿ serpin ⊿ spcStrain; A3:NCC2705 bifidus longum bb genome; A0: negative control; B1: ⊿ serpinStrain; B2: ⊿ serpin ⊿ spcStrain; B3: Bifidobacterium longum NCC2705 genome; B0: negative control.
Figure 15 promotor.
Embodiment
Embodiment 1: the structure of bifidus bacillus targeting vector and shuttle expression carrier:
1. in view of the characteristics of LoxP site sequence, directly synthesize on the pUC57 carrier in LoxP that both direction is identical site, sequence (totally 108 bp) from EcoR V site and PstInsert in the I site, will insert respectively spectinomycin resistance gene from centre and the two ends in two LoxP sites afterwards spcHomology arm sequence with upstream and downstream.
This step carrier construction pUC57-LoxP.Two synthetic LoxP site sequences are:
5 '-CGG ACTAGTATAACTTCGTATAATGTATGCTATACGAAGTTAT CTCGAGAACGATCGGTT GGGCCCATAACTTCGTATAATGTATGCTATACGAAGTTAT AGATCTCC-3 ' (SEQ ID.NO.1), restriction endonuclease is followed successively by SpeI, XhoI, ApaI, BglII.
2. take the pER8 plasmid as template, design primer P-Spc-F:5 '-CCG CTCGAGTGGTCCAGAACCTTGACCG-3 ' ( XhoI), (SEQ. ID.NO.2)
P-Spc-R:5 '-CCC GGGCCCTTATTTGCCGACTACCTTGGTG-3 ' ( ApaI),, (SEQ. ID.NO.3) spectinomycin resistance gene that increases, amplification system (40 μ L: comprise pER8 plasmid dilution template 4 μ L, 2 * Taq mix, 20 μ L, 10 μ M primer pair 4 μ L, ddH 2O 12 μ L), the pcr amplification condition be 95 ℃ 10 minutes, then through 95 ℃ 50 seconds, 60 ℃ 40 seconds, 72 1 minute 30 times circulations, 72 ℃ 10 minutes, PCR product process XhoI and ApaTwo the cutting afterwards of I is connected with the pUC57-LoxP carrier, carrier construction pUC-Spc.Fig. 1 is targeting vector building process schematic diagram, and Fig. 2 is pUC-Spc double digestion the result.
3. design primer Serpin-up800-F:5 '-CCG GAATTCAACCAGCACGTCAGGCC-3 ' ( EcoR I), (SEQ. ID.NO.4), Serpin-up800-R:5 '-CGG ACTAGTGGTTGGCCCCTTTGCTTG-3 ' ( SpeI), (SEQ. ID.NO.5) with the genome of Bifidobacterium longum NCC2705 as masterplate, amplification SerpinUpstream 800 bp fragments, amplification system (40 μ L: comprise the genome dilution template 4 μ L of NCC2705,2 * Taq mix, 20 μ L, 10 μ M primer pair 4 μ L, ddH 2O 12 μ L), the pcr amplification condition be 95 ℃ 10 minutes, then through 95 ℃ 30 seconds, 57 ℃ 40 seconds, 72 1 minute 30 times circulations, 72 ℃ 10 minutes, PCR product process EcoR I and SpeTwo the cutting afterwards of I is connected with pUC-Spc, successful carrier construction pUC-spc-serpin Up800Fig. 3 is pUC-spc-serpin Up800The double digestion the result.
4. design primer Serpin-down800-F:5 '-GGA AGATCTTACTTTCCTGGCAGTCCGTC-3 ' ( BglII) (SEQ. ID.NO.6)
Serpin-down800-R:5 '-CCC AAGCTTCGTACACATACCAGGCGCG-3 ' ( HindIII), (SEQ. ID.NO.7) with the genome of Bifidobacterium longum NCC2705 as masterplate, amplification SerpinDownstream 800 bp gene fragments, amplification system 40 μ L: comprise the genome dilution template 4 μ L of Bifidobacterium longum NCC2705,2 * Taq mix, 20 μ L, 10 μ M primer pair 4 μ L, ddH 2O 12 μ L, the pcr amplification condition be 95 ℃ 10 minutes, then through 95 ℃ 30 seconds, 56 ℃ 40 seconds, 72 1 minute 30 times circulations, 72 ℃ 10 minutes, PCR product process BglII and HindIII is two cuts afterwards and pUC-spc-serpin Up800Connect successful carrier construction pUC-spc-serpin Up+downBe UPD.Fig. 4 is targeting vector pUC-spc-serpin Up+downIt is UPD double digestion checking electrophoresis result.
5. take the recombinant plasmid pDG7 that contains bifidus bacillus endogenous replicon as skeleton, 200 bp(of synthetic Hup gene start codon and upstream thereof comprise the Hu promoter sequence), and add multiple clone site (MCS) after its sequence, add respectively restriction enzyme site in its two ends EcoRI and SalI, double digestion is connected to pDG7, successfully builds shuttle expression carrier pDG-Hup.Fig. 7 is that the pDG-Hup enzyme is cut the result.
Synthetic promoter sequence (totally 283 bp) (as Figure 15)
6. design primer Cre-F:5 '-CCGCTCGAGATGTCCAATTTACTGACCGTACACC-3 ' XhoI, (SEQ. ID.NO.9)
Cre-R:5 '-CGCGTCGACCTAATCGCCATCTTCCAGCAG-3 ' SalI, (SEQ. ID.NO.10) Take pCrepA plasmid (containing Cre enzyme gene) as template, amplification Cre enzyme gene.Amplification system 40 μ L: comprise pCrepA plasmid dilution template 4 μ L, 2 * Pfu mix, 20 μ L, 10 μ M primer pair 4 μ L, ddH 2O 12 μ L, the pcr amplification condition be 95 ℃ 10 minutes, then through 95 ℃ 30 seconds, 62 ℃ 40 seconds, 72 1 minute 30 times circulations, 72 ℃ 10 minutes, PCR product process XhoI and SalI is two cut after, with pDG-Hup, be connected, successfully build pDG-Hup-Cre.Fig. 5 is the Cre-loxP system schematic, and Fig. 6 is recombinant plasmid pDG-Hup-Cre collection of illustrative plates.
Embodiment 2: bifidus longum bb protoplast preparation and conversion:
1. the conversion of targeting vector: Bifidobacterium longum NCC2705 is transferred to (MRS nutrient agar: peptone 10 g, extractum carnis 10 g, yeast extract paste 5 g, Tween-80 1 g, K on the MRS flat board from the glycerine pipe of-70 ℃ of preservations 2HPO 42 g, CH 3COONa3H 2O 5 g, Citric Acid three ammonium 2 g, MgSO 47H 2O 0.2 g, MnSO 4H 2O 0.05 g, Agar 15 g, glucose 20 g, adding distil water to 1000 mL transfers 6.4,121 ℃ of autoclaving 15 min of pH 6.2-.The MRS broth culture: the same agar that do not add of composition), 37 ℃ of anaerobism are cultivated 24 h.Choose a single bacterium colony from flat board, be inoculated in 5 mL MRS liquid nutrient mediums, 37 ℃ of anaerobism are cultivated 24 h; Then transfer in 25 fresh mL MRS liquid nutrient mediums with the inoculum size of 3% (V/V), 37 ℃ of anaerobism are cultivated 24 h; Centrifugal collection thalline, resuspended; Adding mutanolysin to final concentration is 4.5-5.5 mg/L, 36-38 ℃ enzymolysis 25-35 minute; Be resuspended in SMM(Hepes (4-hydroxyethyl piperazine ethanesulfonic acid) 0.02 M/L, magnesium chloride 1 mM/L, raffinose 0.5 M/L) in solution, obtain the bifidus bacillus protoplastis.The targeting vector plasmid pUC-spc-serpin that adds 50 μ L precoolings in the protoplastis of 500 μ L bifidus longum bbs Up+down(plasmid DNA amount<5 μ g) add 40% (v/v) PEG6000 solution, 1.5 mL(of preheating to contain magnesium ion concentration 20 mM/L) the fusion conversion.Add SMMP(liquid regeneration culture medium after conversion: SMM=3:1) solution washing is 2 times.Add 1 mLSMMP recovery 1 h.After recovery, bacterium liquid is coated on spectinomycin (final concentration 100 μ g/mL) regeneration solid medium (tryptone 5.0 g, yeast extract 5.0 g, aminothiopropionic acid hydrochloride 0.4 g, glucose 5.0 g, KH 2PO 42.5 g, CH 3COONa 10.0 g, CaCl 22H 2O 5.0 g, MgCl 26H 2O 5.0 g, agar 15.0 g, raffinose 0.2-0.3M/L transfers 6.5,115 ℃ of autoclaving 20 min of pH) the upper 2-3 of cultivation d; Obtain ⊿ serpinStrain;
2. picking ⊿ serpinBacterium colony is activated in the MRS liquid nutrient medium of 100 μ g/mL spectinomycin resistances.Extract ⊿ serpinStrain bifidus bacillus genomic dna, as template, design primer serpin-F:5 '-ACC AAT CGC TGC TAA GTT CG-3 ' (SEQ. ID.NO.11), R:5 '-GAA CCG GTG TCG ATC ATC TT-3 ' (SEQ. ID.NO.12) amplification serpin gene, amplification system (10 μ L: the genome dilution template 1 μ L that comprises transformant, 2 * Taq mix, 5 μ L, 10 μ M primer pair 1 μ L, ddH 2O 3 μ L), the pcr amplification condition be 95 ℃ 10 minutes, then through 95 ℃ 30 seconds, 60 ℃ 40 seconds, 72 1 minute 30 times circulations, 72 ℃ 10 minutes, detect before and after restructuring SerpinThe variation of gene signal; With primer spc-F/R(SEQ. ID.NO.2 and SEQ. ID.NO.3) amplification spcGene, amplification system is with amplification system and the response procedures in 2 steps in embodiment 1, after detecting restructuring spcGene signal.Be verified as positive ⊿ serpinStrain is activated in the MRS liquid nutrient medium of 100 μ g/mL spectinomycin resistances.
3. will ⊿ serpinThe protoplastis competent cell is made in strain, and shuttle expression carrier pDG-Hup-Cre is imported ⊿ serpinStrain adds 40% (v/v) PEG6000 solution, 1.5 mL(of preheating to contain magnesium ion concentration 20 mM/L) the fusion conversion.Bacterium colony after transforming is coated on regeneration solid medium (tryptone 5.0 g, yeast extract 5.0 g, aminothiopropionic acid hydrochloride 0.4 g, glucose 5.0 g, the KH of 25 μ g/mL amicillin resistances 2PO 42.5 g, CH 3COONa 10.0 g, CaCl 22H 2O 5.0 g, MgCl 26H 2O 5.0 g, agar 15.0 g, raffinose 0.2-0.3M/L transfers 6.5,115 ℃ of autoclaving 20 min of pH) on, obtain possible ⊿ serpin ⊿ spcStrain.
4. picking ⊿ serpin ⊿ spcBacterium colony is activated in 25 μ g/mL amicillin resistance MRS liquid nutrient mediums.Extract ⊿ serpinStrain bifidus bacillus genomic dna is as template, with primer spc-F/R(SEQ. ID.NO.2 and SEQ. ID.NO.3) amplification spcGene, amplification system is with amplification system and the response procedures in 2 steps in embodiment 1, after detecting restructuring spcGene signal.The bacterial strain that no longer carries spectinomycin resistance gene is positive ⊿ serpin ⊿ spcStrain.Screening obtains ⊿ serpin ⊿ spcStrain is activated to the MRS substratum of not being with resistance and uploads culture, further checking.
Embodiment 3: bifidus bacillus SerpinThe checking of gene-deleted strain:
With ⊿ serpin ⊿ spcPnca gene group DNA is template, with primer serpin-F/R(SEQ. ID.NO.11 and SEQ. ID.NO.12) amplification SerpinGene (amplification system and response procedures are with step 2 in embodiment 2) detects in regrouping process SerpinThe variation of gene signal; With primer SEQ. ID.NO.2 and SEQ. ID.NO.3 amplification spcGene detects shuttle expression carrier and transforms front and back spcGene signal.Figure 10 is the PCR the result after substep transforms, warp SerpinThe amplification of genetically deficient fragment PCR and 1% agarose gel electrophoresis show ⊿ serpinStrain can amplify 1000 bp, shows in the transformant genome to contain spcGene; ⊿ serpinStrain fail the to increase fragment of 1400 bp shows that homologous recombination has occured the homologous fragment on target practice fragment and karyomit(e), SerpinThe gene quilt spcGene substitution has built SepinGene-deleted strain; Yet ⊿ serpin ⊿ spcStrain is failed to increase and is arrived SerpinGene has also lost spcThe signal of gene, this illustrates under the help of shuttle expression carrier, the resistant gene between Cre recombinase LoxP site that both direction is identical spcFragment has been deleted.
With ⊿ serpin ⊿ spcThe genomic dna of strain is template, with primer Cre-F/R amplification cre gene, and PCR checking pDG-Hup-Cre positive transformant (amplification system is with 6 step implementation steps in embodiment 1), and extract the recombinant plasmid enzyme and cut checking.Fig. 9 is for transforming dull and stereotyped photo, and the positive transformant PCR of Figure 10 proof diagram, Figure 11 are that pDG-Hup-Cre transforms the PCR checking and enzyme is cut proof diagram.Result shows, shuttle expression carrier pDG-Hup-Cre has successfully imported bifidus bacillus.
3. Figure 12 is that glass bead method is extracted the bifidus longum bb genomic dna, and electrophoresis result shows.Electrophoretic band concentrates on 15000 bp, and the genome effect of extraction is better, can be used for further dotting or Southern hybridization check.Take spectinomycin spc digoxigenin labeled fragment T-spc as probe, SerpinLabeled fragment T-serpin is that probe carries out respectively the dotting checking.Figure 13 shows ⊿ serpinStrain He ⊿ serpin ⊿ spcStrain pair SerpinGene all is revealed as feminine gender, ⊿ serpinStrain pair spcThe spectinomycin gene is aobvious positive, and ⊿ serpin ⊿ spcStrain pair spcThe spectinomycin gene is revealed as feminine gender, the result demonstration, and the Cre recombinase successfully will spcGene has removed from the genome of bifidus bacillus recombinant bacterial strain.
4. will screen ⊿ serpinStrain and ⊿ serpin ⊿ spcSouthern hybridization checking is carried out in strain.Figure 14 shows that positive control A3 presents single band when hybridizing with the T-serpin probe, and A1/A2 is all without band, namely ⊿ serpinStrain and ⊿ serpin ⊿ spcIn strain without SerpinGene signal; When hybridizing with the T-spc probe, B1 ⊿ serpinStrain presents single band, and B3 is that the bifidus bacillus prime strain does not present band, namely ⊿ serpinIntroduced the spectinomycin resistance gene of external source in strain transformant genome, band does not appear in B2, explanation ⊿ serpin ⊿ spcOn the pnca gene group spcResistant gene has been removed by the restructuring of Cre recombinase, has realized that successfully the seamless of bifidus bacillus knocks out.
These are only specific embodiments of the invention, do not limit protection scope of the present invention with this; Any replacement and the improvement done on the basis of not violating the present invention's design all belong to protection scope of the present invention.
Sequence table
<110〉University Of Nanchang
<120〉foundation of the seamless knockout technique of bifidus bacillus functional gene
<160> 12
<170> PatentIn version 3.1
<210> 1
<211> 108
<212> DNA
<213〉artificial sequence
<400> 1
cggactagta taacttcgta taatgtatgc tatacgaagt tatctcgaga 50
acgatcggtt gggcccataa cttcgtataa tgtatgctat acgaagttat 100
agatctcc 108
<210> 2
<211> 28
<212> DNA
<213〉artificial sequence
<400> 2
ccgctcgagt ggtccagaac cttgaccg 28
<210> 3
<211> 31
<212> DNA
<213〉artificial sequence
<400> 3
cccgggccct tatttgccga ctaccttggt g 31
<210> 4
<211> 26
<212> DNA
<213〉artificial sequence
<400> 4
ccggaattca accagcacgt caggcc 26
<210> 5
<211> 27
<212> DNA
<213〉artificial sequence
<400> 5
cggactagtg gttggcccct ttgcttg 27
<210> 6
<211> 29
<212> DNA
<213〉artificial sequence
<400> 6
ggaagatctt actttcctgg cagtccgtc 29
<210> 7
<211> 28
<212> DNA
<213〉artificial sequence
<400> 7
cccaagcttc gtacacatac caggcgcg 28
<210> 8
<211> 283
<212> DNA
<213〉artificial sequence
<400> 8
cgcggatccc attccgctgg gcgcggcggc catgaagtgg cttgacaagc 50
ataatcttgt ctgattcgtc tattttcata cccccttcgg ggaaatagat 100
gtgaaaaccc ttataaaacg cgggttttcg cagaaacatg cgctagtatc 150
attgatgaca acatggacta agcaaaagtg cttgtcccct gacccaagaa 200
ggatgcttta tgctcgagga gctcgggccc ggtacctacg taagatctgc 250
ggccgccctg caggactagt gtcgacgtcg gcc 283
<210> 9
<211> 34
<212> DNA
<213〉artificial sequence
<400> 9
ccgctcgaga tgtccaattt actgaccgta cacc 34
<210> 10
<211> 30
<212> DNA
<213〉artificial sequence
<400> 10
cgcgtcgacc taatcgccat cttccagcag 30
<210> 11
<211> 20
<212> DNA
<213〉artificial sequence
<400> 11
accaatcgct gctaagttcg 20
<210> 12
<211> 20
<212> DNA
<213〉artificial sequence
<400> 12
gaaccggtgt cgatcatctt 20

Claims (6)

1. the establishment method of the seamless gene-deleted strain of bifidus bacillus functional gene, is characterized in that, comprises the following steps:
(1) SEQ ID.NO.1 is cut by EcoR V site and Pst I enzyme be connected on the pUC57 carrier, obtain the pUC57-LoxP carrier;
(2) take the pER8 plasmid as template, by primer SEQ. ID.NO.2 and SEQ. ID.NO.3 amplification spectinomycin resistance gene spc, amplified production be connected with Apa I through Xho I is connected with the pUC57-LoxP carrier after cutting, structure obtains carrier pUC-Spc;
(3) with the genome of bifidus bacillus as template, by primer SEQ. ID.NO.4 and SEQ. ID.NO.5 amplification, amplified production be connected with Spe I through EcoR I be connected with the pUC-Spc carrier after cutting, structure obtains carrier pUC-spc-serpin Up800
(4) with the genome of bifidus bacillus as template, by primer SEQ. ID.NO.6 and SEQ. ID.NO.7 amplification, with amplified production through Bgl II and the Hind III is two cut after with pUC-spc-serpin Up800Carrier connects, and builds to obtain targeting vector plasmid pUC-spc-serpin Up+down, i.e. UPD;
(5) SEQ. ID.NO.8 sequence is connected to pDG7 through EcoR I and Sal I double digestion, builds shuttle expression carrier pDG-Hup;
(6) take the pCrepA plasmid that contains Cre enzyme gene as template, by primer SEQ. ID.NO.9 and SEQ. ID.NO.10 amplification Cre enzyme gene; Amplified production through Xho I and Sal I are two cut after, is connected with pDG-Hup, structure obtains pDG-Hup-Cre;
(7) conversion of targeting vector: with targeting vector plasmid pUC-spc-serpin Up+downJoin in the bifidus bacillus protoplastis, merge conversion; Washing, recovery after recovery are coated on bacterium liquid and cultivate 2-3 d on the regeneration culture medium with spectinomycin, and De is Dao ⊿ serpin strain;
(8) make the protoplastis competent cell Jiang ⊿ serpin strain, with shuttle expression carrier pDG-Hup-Cre Dao Ru ⊿ serpin strain, merge and transform, bacterium colony after transforming is coated on the regeneration culture medium of amicillin resistance, screens the seamless disappearance of the bifidus bacillus serpin gene Zhu ⊿ serpin ⊿ spc strain of no longer carrying spectinomycin resistance gene.
2. establishment method according to claim 1, it is characterized in that, the condition that fusion described in step (7) and step (8) transforms is: join containing in the solution that magnesium ion concentration is 20 ± 1mM/L, 40 ± 1% (v/v) PEG6000 of preheating, merge conversion.
3. establishment method according to claim 1, is characterized in that, in step (7), described bifidus bacillus protoplast preparation is: the bifidus bacillus of preservation is transferred on the MRS flat board, and 37 ± 1 ℃ of anaerobism are cultivated 20-26 h; Choose a single bacterium colony from flat board, be inoculated in the MRS liquid nutrient medium, 37 ± 1 ℃ of anaerobism are cultivated 20-26h; Transfer in fresh MRS liquid nutrient medium with 3 ± 1%(v/v) inoculum size, 37 ± 1 ℃ of anaerobism are cultivated 20-26 h; Centrifugal collection thalline, resuspended; Adding mutanolysin to final concentration is 4.5-5.5 mg/L, 36-38 ℃ enzymolysis 25-35 minute; Be resuspended in SMM solution, obtain the bifidus bacillus protoplastis.
4. according to claim 1-3 described establishment method of any one, is characterized in that, described bifidus bacillus is bifidus longum bb.
5. seamless gene-deleted strain of bifidus bacillus functional gene that does not carry spectinomycin resistance gene.
6. the seamless gene-deleted strain of described bifidus bacillus functional gene according to claim 5, it is to be prepared by the described method of claim 1-4 any one.
CN201310070885.8A 2013-03-06 2013-03-06 Establishing method of bifidobacterium functional gene no-trace knockout method Expired - Fee Related CN103146739B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310070885.8A CN103146739B (en) 2013-03-06 2013-03-06 Establishing method of bifidobacterium functional gene no-trace knockout method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310070885.8A CN103146739B (en) 2013-03-06 2013-03-06 Establishing method of bifidobacterium functional gene no-trace knockout method

Publications (2)

Publication Number Publication Date
CN103146739A true CN103146739A (en) 2013-06-12
CN103146739B CN103146739B (en) 2014-11-26

Family

ID=48545057

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310070885.8A Expired - Fee Related CN103146739B (en) 2013-03-06 2013-03-06 Establishing method of bifidobacterium functional gene no-trace knockout method

Country Status (1)

Country Link
CN (1) CN103146739B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106032537A (en) * 2015-03-10 2016-10-19 中国科学院微生物研究所 Hygromycin resistant gene and application thereof
CN114761563A (en) * 2019-05-15 2022-07-15 鹿园益生菌和酵素有限公司 Inducible plasmid self-destruction assisted recombination

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429520A (en) * 2008-11-10 2009-05-13 天津科技大学 Epiphyte genome conformity plasmid pUNFIN without selection mark, construction method and uses thereof
CN101812475A (en) * 2009-11-19 2010-08-25 无锡亚克生物科技有限公司 Recombinant vector pGAprEHS for expressing Harpin protein and engineering bacteria thereof
CN102094036A (en) * 2010-12-13 2011-06-15 西北农林科技大学 Allele double knockout targeting vector system and construction method thereof
WO2011100250A1 (en) * 2010-02-09 2011-08-18 The Trustees Of Columbia University In The City Of New York In vivo gene regulation by the combination of knock- in-teto sequence into the genome and tetracycline-controlled trans-suppressor (tts) protein
CN102250937A (en) * 2011-05-30 2011-11-23 黑龙江省科学院微生物研究所 Construction method of recombinant plasmid vector p18-kan+/- containing loxP-kanr-loxP segments

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429520A (en) * 2008-11-10 2009-05-13 天津科技大学 Epiphyte genome conformity plasmid pUNFIN without selection mark, construction method and uses thereof
CN101812475A (en) * 2009-11-19 2010-08-25 无锡亚克生物科技有限公司 Recombinant vector pGAprEHS for expressing Harpin protein and engineering bacteria thereof
WO2011100250A1 (en) * 2010-02-09 2011-08-18 The Trustees Of Columbia University In The City Of New York In vivo gene regulation by the combination of knock- in-teto sequence into the genome and tetracycline-controlled trans-suppressor (tts) protein
CN102094036A (en) * 2010-12-13 2011-06-15 西北农林科技大学 Allele double knockout targeting vector system and construction method thereof
CN102250937A (en) * 2011-05-30 2011-11-23 黑龙江省科学院微生物研究所 Construction method of recombinant plasmid vector p18-kan+/- containing loxP-kanr-loxP segments

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
PAUL A. BEARE ET AL.: "Two Systems for Targeted Gene Deletion in Coxiella burnetii", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》 *
SENDAI, Y ET AL.: "alpha 1,3-galactosyltransferase-gene knockout in cattle using a single targeting vector with loxP sequences andcre-expressing adenovirus", 《TRANSPLANTATION》 *
万翠香 等: "双歧杆菌原生质体的制备及其转化系统的建立", 《食品与发酵工业》 *
崔佳 等: "Serpin多抗制备和产Serpin的双歧杆菌菌株的初步筛选", 《食品与生物技术学报》 *
章昭琳: "双歧杆菌原生质体的制备及serpin缺失株的构建", 《中国优秀硕士学位论文全文数据库·基础科学辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106032537A (en) * 2015-03-10 2016-10-19 中国科学院微生物研究所 Hygromycin resistant gene and application thereof
CN114761563A (en) * 2019-05-15 2022-07-15 鹿园益生菌和酵素有限公司 Inducible plasmid self-destruction assisted recombination

Also Published As

Publication number Publication date
CN103146739B (en) 2014-11-26

Similar Documents

Publication Publication Date Title
CN107400677B (en) Bacillus licheniformis genome editing vector based on CRISPR-Cas9 system and preparation method thereof
CN105671070B (en) A kind of CRISPRCas9 system and its construction method for Bacillus subtilis genes group editor
US10738314B2 (en) IrrE protein functional domain for improving anti-oxidation capability of cell and application thereof
Wang et al. Advances allowing feasible pyrG gene editing by a CRISPR-Cas9 system for the edible mushroom Pleurotus eryngii
Niu et al. High yield recombinant thermostable α-amylase production using an improved Bacillus licheniformis system
CN105420154A (en) Double knockout recombinant rhodococcus as well as construction method and application thereof
CN105695383A (en) Recombinant strain and application thereof
US10947519B2 (en) Yeast strains co-expressing exogenous glucoamylases, the method for obtaining said yeast strains and the use thereof to produce bioethanol
CN105821071A (en) Unmarked gene knock-out method of pediococcus acidilactici DQ2 based on homologous recombination
CN103146739B (en) Establishing method of bifidobacterium functional gene no-trace knockout method
CN107779466A (en) Method for higher fungus gene disruption
CN104630256A (en) Construction and application of ganoderma manganese peroxidase pichia pastoris gene engineering strain
JPWO2020027010A1 (en) Method for producing mutant strain and protein of Trichoderma filamentous fungus
CN105063078A (en) Construction method of recombinant bacillus subtilis for integration and expression of foreign protein by virtue of Tn7 transposable element
He et al. Direct production of ethanol from raw sweet potato starch using genetically engineered Zymomonas mobilis
CN115948316B (en) Method for improving acid resistance of lactic acid bacteria
CN106591351A (en) Recombinant saccharomyces cerevisiae utilizing starch and secreting antibacterial peptide
WO2020134427A1 (en) Use of sll0528 gene in improving ethanol tolerance of synechocystis sp. pcc 6803
KR102026934B1 (en) A Novel host stain Leuconostoc citreum EFEL2701 for production of recombinant target protein and uses thereof
CN106854657A (en) It is a kind of assistant degradation protein and the prebiotic recombinant Saccharomyces cerevisiae of antibacterial peptide to be secreted
CN103320373B (en) The Arthrobacter of one strain process LAN Hypoxanthine phospho-ribosyl transferase and construction process thereof and application
CN115948265A (en) Kluyveromyces marxianus haploid yeast and construction method and application thereof
CN103305544B (en) Acarbose engineering bacterium as well as preparation method and application thereof
Boňková et al. Upstream regulatory regions controlling the expression of the Candida utilis maltase gene
CN106636176B (en) A kind of prebiotic feeding saccharomyces cerevisiae for producing xylo-oligosaccharide and antibacterial peptide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141126

Termination date: 20150306

EXPY Termination of patent right or utility model